Researchers found a protein that's essential for an enterovirus to enter human cells. Although not the infamous example—that ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Biotechnology company Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its ...

As described in the journal Cell, the researchers analyzed the autoantibodies ... “By mapping antibody binding sites on the ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

In fact, 34% of FDA-approved drugs are based on these receptors. "Having detailed information about the specific site where these drugs act within the cell will accelerate the development of ...

The granted patents titled “System and Methods For Immune Cells Expansion and Activation In Large Scale” focus on a system and method for culturing and/or activating immune cells in a large scale, ...

Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via ...